NIH Funds SDBRI Group to Develop a Vaccine Against HIV Infection

Dr. Binley’s research group received NIH funding to build on earlier progress to develop a vaccine that is globally protective against HIV infection. His approach is to develop a safe and effective “Jennerian” particle vaccine platform to elicit neutralizing antibodies against HIV-1.

We need your help

Our research programs are funded primarily by grants from the National Institutes of Health (NIH). Private donations help to accelerate the progress of research through the purchase of laboratory supplies and equipment or the recruitment of additional laboratory personnel. Thank you!

Donate Now